Expression of the cancer stem cell marker CD133 in CTCs of metastatic breast, colon, colorectal, renal cell, hepatocellular and non-small cell lung cancer patients [266, 269–257]. The gene discussed is PROM1; the disease is non-small cell lung carcinoma.